From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment.

@article{Babula2013FromNA,
  title={From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment.},
  author={Petr Babula and Michal Masarik and Vojtěch Adam and Ivo Provazn{\'i}k and Ren{\'e} Kizek},
  journal={Anti-cancer agents in medicinal chemistry},
  year={2013},
  volume={13 7},
  pages={
          1069-87
        }
}
The cardiac glycosides are a group of compounds isolated from plants and some animals. They have been used in therapy for heart failure for many years. The cytotoxic effect of many cardiac glycosides has been demonstrated, but the mechanism of action is very complicated and complex, and Na+/K+-ATPase surely plays a crucial role in it. On the other hand, Na+/K+-ATPase is regulated by many endogenous factors, such as hormones or FXYD proteins, whose role in regulating the cell cycle has been… Expand
Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides
TLDR
Experimental approaches that could be used to reveal the cancer therapeutic potential of cardiac glycosides in preclinical studies are discussed. Expand
Cytotoxic effects of the cardenolide convallatoxin and its Na,K-ATPase regulation
TLDR
It was found that CON induced cytostatic and cytotoxic effects in A549 cells, showing essentially apoptotic cell death, as detected by annexin V-propidium iodide double-staining, as well as changes in cell form. Expand
Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol
TLDR
It is shown that POH acts in signaling cascades associated with NKA that control cell proliferation and/or cellular death, and may have an important role in the anti-tumor action of POH in GBM cells. Expand
Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells
TLDR
The results indicated that arenobufagin might directly bind with Na, K-ATPase α1 and α3 subunits and the inhibitive effect of arenOBufagin on proteasomal activity of HeLa cells might be related to its binding with Na. Expand
Targeting Na+/K+‐translocating adenosine triphosphatase in cancer treatment
TLDR
The clinical evidence supporting the use of Na+/K+‐ATPase inhibitors as anticancer drugs is weak and well‐designed randomized clinical trials with reasonable sample sizes are certainly warranted to confirm the efficacy and safety of cardiac glycosides for the treatment of cancer. Expand
Quantitative Proteomics Reveals That the Inhibition of Na(+)/K(+)-ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells.
TLDR
Ouabain induced chromosome segregation disorder and S-cell cycle block by decreasing the expression of AURKA, SMC2, Cyclin D, and p-CDK1 as well as increasing theexpression of p53, and the findings suggest that AURka is involved in the anticancer mechanisms of ouabains in HepG2 cells. Expand
Cardenolides: Insights from chemical structure and pharmacological utility
TLDR
Some of the structural features of this class of natural products that are crucial for their efficacy are highlighted, some methods of isolating these compounds from natural resources, and the structural elucidation tools that have been used are described. Expand
Cardenolides from the Apocynaceae family and their anticancer activity.
TLDR
The phytochemical characteristics and anticancer activity of the cardenolides from this family are compiled to exhibit the capability to regulate cancer cell survival and death through multiple signaling pathways. Expand
(+)-Strebloside-Induced Cytotoxicity in Ovarian Cancer Cells Is Mediated through Cardiac Glycoside Signaling Networks.
TLDR
In spite of its antitumor potential, the overall biological activity of (+)-strebloside must be regarded as being typical of better-known cardiac glycosides such as digoxin and ouabain. Expand
Synthesis and evaluation of cytotoxic and Na+/K+-ATP-ase inhibitory activity of selected 5α-oleandrigenin derivatives.
TLDR
The synthesis of oleandrigenin model, 16β-hydroxy-3β-methoxy-5α-card-20(22)-enolide 16-acetate, from androstenolone acetate through 17β-(3-furyl)-intermediates has been developed and comparison of Na+/K+-ATP-ase inhibitory and cytotoxic activity underlines complex nature of the relationship. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 342 REFERENCES
Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis
TLDR
The finding that cardiac glycosides inhibit protein synthesis provides a mechanism for the cytotoxicity of CGs and raises concerns about ongoing clinical trials to test CGs as anti-cancer agents in humans. Expand
Digitoxin-Induced Cytotoxicity in Cancer Cells Is Mediated through Distinct Kinase and Interferon Signaling Networks
TLDR
This study investigated the cytotoxic properties of cardiac glycosides against a panel of pancreatic cancer cell lines, explored their apoptotic mechanism, and characterized the kinetics of cell death induced by these drugs. Expand
Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways.
TLDR
This work provides first evidence showing that the cardiac glycosides induce autophagy in human NSCLC cells through regulation of both mTOR and ERK1/2 signaling pathways. Expand
Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells.
TLDR
It is reported that the cardiac glycosides oleandrin, ouabain, and digoxin induce apoptosis in androgen-independent human prostate cancer cell lines in vitro, defining a novel activity for cardiac Glycosides that could prove relevant to the treatment of metastatic prostate cancer. Expand
Synthesis and evaluation of cardiac glycoside mimics as potential anticancer drugs.
TLDR
To mimic the labile trisaccharide of digitoxin with a stabile carbohydrate surrogate, sulfur linked ethylene glycol moieties are used and the shortest mimics were found to have highest efficacy and cytotoxic effect on cancerous MCF-7 cells. Expand
The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cells.
TLDR
The hemi-synthetic cardenolide 19-hydroxy-2''oxovoruscharin is impressively active in cancer cells expressing diverse forms of multi-drug resistance (MDR) either conferred by the over-expression of selected drug-transporter proteins or induced by a range of chemotherapeutic agents. Expand
Novel therapeutic applications of cardiac glycosides
TLDR
The increased susceptibility of cancer cells to these compounds supports their potential use as cancer therapies, and the first generation of glycoside-based anticancer drugs are currently in clinical trials. Expand
Na+/K+-ATPase α3 mediates sensitivity of hepatocellular carcinoma cells to bufalin.
TLDR
This study demonstrated that bufalin inhibited the growth of hepatocellular carcinoma (HCC) cells in a dose-dependent manner, which correlated with the expression level of Na+/K+-ATPase α3 in HCC cells. Expand
Cardiac steroids induce changes in recycling of the plasma membrane in human NT2 cells.
TLDR
The data indicate that the CS-induced accumulation of cytoplasmic membrane components is a result of inhibited recycling within the late endocytic pathway, and support the notion that theCS-induced changes in membrane traffic is mediated by the Na+, K(+)-ATPase. Expand
Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells.
TLDR
The results suggest that the efficacy of chemotherapeutic agent substrates of Pgp may be strongly reduced in patients taking digoxin and that the administration of cardioactive glycosides may widely affect the absorption of drugs in colon epithelia. Expand
...
1
2
3
4
5
...